Clinical Trial Update: A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of PPC-06 (Tepilamide Fumarate) in psoriasis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• PPC-06 (Tepilamide Fumarate) (Tepilamide Fumarate)

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2021-05-11